ResMed CEO Michael J. Farrell Sells 8,009 Shares
Okuma süresi: 1 dakikadan kısa
| Reporter Name | Farrell Michael J. |
| Relationship | Chief Executive Officer |
| Type | Sell |
| Amount | $2,056,076 |
| SEC Filing | Form 4 |
ResMed's Chief Executive Officer, Michael J. Farrell, sold 8,009 shares of the company's common stock on July 7, 2025, at a weighted average price of $256.7207, totaling $2,056,076. Following the transaction, Farrell directly owns 455,503 shares of ResMed. The sale was conducted under a Rule 10b5-1 plan adopted on October 31, 2024.
SEC Filing: RESMED INC [ RMD ] - Form 4 - Jul. 09, 2025